Emtora Biosciences Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $16.9M

  • Investors
  • 4

Emtora Biosciences General Information

Description

Developer of novel therapeutics designed to prevent the onset and recurrence of cancer. The company creates a novel formulation of rapamycin that slows down the aging process, regenerates the immune system, and prevents cancer progression, enabling medical practitioners to treat patients suffering from cancer.

Contact Information

Formerly Known As
Rapamycin Holdings
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 16601 Blanco Road
  • Suite 120
  • San Antonio, TX 78232
  • United States
+1 (210)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 16601 Blanco Road
  • Suite 120
  • San Antonio, TX 78232
  • United States
+1 (210)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Emtora Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Grant 17-Aug-2022 $16.9M Completed Clinical Trials - Phase 3
9. Grant 01-Jan-2022 Completed Clinical Trials - Phase 3
8. Grant 26-Aug-2019 Completed Clinical Trials - Phase 2
7. Later Stage VC (Series A1) 09-Aug-2019 Completed Clinical Trials - Phase 2
6. Later Stage VC 16-Feb-2018 Cancelled Clinical Trials - Phase 1
5. Later Stage VC (Series B) 07-Aug-2017 Completed Clinical Trials - Phase 1
4. Early Stage VC Completed Clinical Trials - Phase 1
3. Early Stage VC 18-Apr-2016 Cancelled Clinical Trials - Phase 1
2. Early Stage VC (Series A) 02-Jun-2015 $3.93M $3.93M Completed Clinical Trials - Phase 1
1. Early Stage VC 09-Jul-2013 Completed Clinical Trials - Phase 1
To view Emtora Biosciences’s complete valuation and funding history, request access »

Emtora Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
Series A
To view Emtora Biosciences’s complete cap table history, request access »

Emtora Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel therapeutics designed to prevent the onset and recurrence of cancer. The company creates a novel form
Drug Discovery
San Antonio, TX
3 As of 2026

East Hanover, NJ

Madison, WI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Emtora Biosciences Competitors (63)

One of Emtora Biosciences’s 63 competitors is Immetas, a Venture Capital-Backed company based in East Hanover, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Immetas Venture Capital-Backed East Hanover, NJ
Centrose Venture Capital-Backed Madison, WI
Apexian Pharmaceuticals Venture Capital-Backed Indianapolis, IN
Rein Therapeutics Formerly VC-backed Austin, TX
ImmunOs Therapeutics Venture Capital-Backed Schlieren, Switzerland
You’re viewing 5 of 63 competitors. Get the full list »

Emtora Biosciences Patents

Emtora Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3131546-A1 Oral rapamycin preparation and use for stomatitis Active 16-Apr-2014
EP-3131546-A4 Oral rapamycin preparation and use for stomatitis Active 16-Apr-2014
US-20170079962-A1 Oral rapamycin preparation and use for stomatitus Inactive 16-Apr-2014
EP-3131546-B1 Oral rapamycin preparation for use in treating feline chronic gingivo- stomatitis (fcgs) Active 16-Apr-2014
US-20150202164-A1 Oral rapamycin nanoparticle preparations Active 31-Dec-2013 A61K31/436
To view Emtora Biosciences’s complete patent history, request access »

Emtora Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Emtora Biosciences Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Cancer Institute Government
Cancer Prevention and Research Institute of Texas Government
Barshop Ventures Family Office Minority
UT Horizon Fund Venture Capital Minority
To view Emtora Biosciences’s complete investors history, request access »

Emtora Biosciences FAQs

  • When was Emtora Biosciences founded?

    Emtora Biosciences was founded in 2012.

  • Where is Emtora Biosciences headquartered?

    Emtora Biosciences is headquartered in San Antonio, TX.

  • What is the size of Emtora Biosciences?

    Emtora Biosciences has 3 total employees.

  • What industry is Emtora Biosciences in?

    Emtora Biosciences’s primary industry is Drug Discovery.

  • Is Emtora Biosciences a private or public company?

    Emtora Biosciences is a Private company.

  • What is Emtora Biosciences’s current revenue?

    The current revenue for Emtora Biosciences is .

  • How much funding has Emtora Biosciences raised over time?

    Emtora Biosciences has raised $24M.

  • Who are Emtora Biosciences’s investors?

    National Cancer Institute, Cancer Prevention and Research Institute of Texas, Barshop Ventures, and UT Horizon Fund have invested in Emtora Biosciences.

  • Who are Emtora Biosciences’s competitors?

    Immetas, Centrose, Apexian Pharmaceuticals, Rein Therapeutics, and ImmunOs Therapeutics are some of the 63 competitors of Emtora Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process